/ACHC
ACHC Stock - Acadia Healthcare Company, Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$14.41-0.14%
$0.02 (-0.14%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.3
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.84
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+46.9%upside
Target: $21.17
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACHC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$14.27 – $14.55
TARGET (TP)$21.17
STOP LOSS$13.26
RISK/REWARD1:5.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.90
52W High$47.08
52W Low$12.63
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B |
| Gross Profit | $711.98M | $682.61M | $2.51B | $2.22B | $2.00B |
| Gross Margin | 22.6% | 23.3% | 96.2% | 96.1% | 95.8% |
| Operating Income | $522.28M | $506.60M | $467.69M | $414.47M | N/A |
| Net Income | $255.61M | $-21,667,000 | $273.14M | $190.63M | $-672,132,000 |
| Net Margin | 8.1% | -0.7% | 10.5% | 8.2% | -32.2% |
| EPS | $2.79 | $-0.24 | $3.05 | $2.15 | $-7.65 |
Company Overview
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
30%
Hold / Neutral
5
50%
Sell / Underperform
2
20%
Analyst Consensus🔴 Bearish
3 Bullish7 Neutral/Bearish
Price Targets
$57
Average Target
↑ 295.6% Upside
Now
$13
Low
$57
Average
$100
High
Based on 13 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 3rd 2025 | Leerink Partners | Downgrade | Market Perform | $14 |
| December 3rd 2025 | BofA Securities | Downgrade | Underperform | $13 |
| September 10th 2025 | BofA Securities | Downgrade | Neutral | $25 |
| August 14th 2025 | Raymond James | Downgrade | Outperform | $26 |
| February 28th 2025 | Barclays | Downgrade | Equal Weight | $35← $43 |
| January 7th 2025 | KeyBanc Capital Markets | Upgrade | Overweight | $70 |
| December 12th 2024 | Deutsche Bank | Upgrade | Buy | $75← $45 |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Sector Weight | - |
| April 25th 2024 | Deutsche Bank | Upgrade | Hold | $70 |
| March 6th 2024 | Barclays | Initiation | Overweight | $100 |
| April 21st 2023 | Cantor Fitzgerald | Initiation | Neutral | $83 |
| April 20th 2023 | Deutsche Bank | Downgrade | Sell | $63← $75 |
| December 12th 2022 | Loop Capital | Upgrade | Buy | $95← $90 |
| June 17th 2022 | Loop Capital | Initiation | Hold | $72 |
Earnings History & Surprises
ACHCBeat Rate
72%
Last 18 quarters
Avg Surprise
+3.9%
EPS vs Estimate
Beats / Misses
13/3
2 met exactly
Latest EPS
$0.72
Q4 2025
EPS Surprise History
Q1 24
+6.2%
$0.85vs$0.80
Q2 24
+3.7%
$0.84vs$0.81
Q3 24
+4.6%
$0.91vs$0.87
Q4 24
+1.1%
$0.91vs$0.90
Q1 25
-14.7%
$0.64vs$0.75
Q2 25
+14.3%
$0.40vs$0.35
Q3 25
+16.9%
$0.83vs$0.71
Q4 25
+5.9%
$0.72vs$0.68
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.10 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.68 | $0.72 | +5.9% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $0.71 | $0.83 | +16.9% | ✓ BEAT |
Q2 2025 | May 12, 2025 | $0.35 | $0.40 | +14.3% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.75 | $0.64 | -14.7% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.90 | $0.91 | +1.1% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $0.87 | $0.91 | +4.6% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $0.81 | $0.84 | +3.7% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $0.80 | $0.85 | +6.2% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.88 | $0.91 | +3.4% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $0.86 | $0.92 | +7.0% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $0.71 | $0.75 | +5.6% | ✓ BEAT |
Q1 2023 | Feb 27, 2023 | $0.75 | $0.70 | -6.7% | ✗ MISS |
Q4 2022 | Oct 31, 2022 | $0.80 | $0.80 | 0.0% | = MET |
Q3 2022 | Jul 27, 2022 | $0.78 | $0.84 | +7.7% | ✓ BEAT |
Q2 2022 | May 3, 2022 | $0.64 | $0.67 | +4.7% | ✓ BEAT |
Q1 2022 | Feb 28, 2022 | $0.68 | $0.67 | -1.5% | ✗ MISS |
Q4 2021 | Oct 28, 2021 | $0.72 | $0.72 | 0.0% | = MET |
Q3 2021 | Aug 2, 2021 | $0.63 | $0.71 | +12.7% | ✓ BEAT |
Latest News
Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $17
➖ NeutralBenzinga•Dec 18, 2025, 01:10 PM
Shares of healthcare stocks are trading higher amid the Republican healthcare bill failing to win enough votes to advance in the Senate.
📈 PositiveBenzinga•Dec 11, 2025, 07:46 PM•Also: , ,
Barclays Maintains Equal-Weight on Acadia Healthcare Co, Lowers Price Target to $14
📉 NegativeBenzinga•Dec 4, 2025, 03:39 PM•Also:
RBC Capital Maintains Outperform on Acadia Healthcare Co, Lowers Price Target to $19
➖ NeutralBenzinga•Dec 3, 2025, 05:10 PM
Cantor Fitzgerald Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $17
➖ NeutralBenzinga•Dec 3, 2025, 04:26 PM
Keybanc Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $25
➖ NeutralBenzinga•Dec 3, 2025, 03:36 PM
UBS Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $24
📈 PositiveBenzinga•Dec 3, 2025, 03:32 PM•Also:
Deutsche Bank Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $20
➖ NeutralBenzinga•Dec 3, 2025, 03:03 PM•Also:
B of A Securities Downgrades Acadia Healthcare Co to Underperform, Lowers Price Target to $13
📉 NegativeBenzinga•Dec 3, 2025, 02:38 PM
Leerink Partners Downgrades Acadia Healthcare Co to Market Perform, Lowers Price Target to $14
📉 NegativeBenzinga•Dec 3, 2025, 01:05 PM
Acadia Healthcare shares are trading lower after the company cut full-year 2025 guidance, updating its professional and general liability reserves due to larger expenses associated primarily with patient-related litigation.
📉 NegativeBenzinga•Dec 3, 2025, 12:32 PM
Acadia Healthcare drops after hours on reduced 2025 guidance
📉 NegativeSeeking Alpha•Dec 2, 2025, 10:47 PM
Acadia Healthcare Projects 2025 PLGL Expense To Surge To ~$116M Vs. $54M In 2024, Net PLGL Liability To Rise To $145M-$165M And Expects 2026 PLGL Costs Of $100M-$110M Amid 168% Claim Spike And Higher IBNR Reserves
📉 NegativeBenzinga•Dec 2, 2025, 09:21 PM
Acadia Healthcare shares are trading lower after the company cut full-year 2025 guidance, updating its professional and general liability reserves due to larger expenses associated primarily with patient-related litigation.
📉 NegativeBenzinga•Dec 2, 2025, 09:20 PM
Acadia Healthcare Cuts 2025 Guidance, Lowering Adjusted EBITDA To $601M-$611M And EPS By $0.41 From $2.35-$2.45 To $1.94–$2.04 Due To Higher Professional & General Liability Costs
📉 NegativeBenzinga•Dec 2, 2025, 09:19 PM
Keybanc Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $30
➖ NeutralBenzinga•Nov 18, 2025, 03:05 PM
RBC Capital Maintains Outperform on Acadia Healthcare Co, Lowers Price Target to $22
➖ NeutralBenzinga•Nov 12, 2025, 02:21 PM
Guggenheim Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $27
➖ NeutralBenzinga•Nov 10, 2025, 02:55 PM
UBS Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $28
➖ NeutralBenzinga•Nov 7, 2025, 06:03 PM•Also:
Cantor Fitzgerald Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $22
➖ NeutralBenzinga•Nov 7, 2025, 04:08 PM
Frequently Asked Questions about ACHC
What is ACHC's current stock price?
Acadia Healthcare Company, Inc. (ACHC) is currently trading at $14.41 per share. The stock has moved -0.14% today.
What is the analyst price target for ACHC?
The average analyst price target for ACHC is $21.17, based on 1 analyst.
What sector is Acadia Healthcare Company, Inc. in?
Acadia Healthcare Company, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is ACHC's market cap?
Acadia Healthcare Company, Inc. has a market capitalization of $1.33 billion, making it a small-cap company.
Does ACHC pay dividends?
No, Acadia Healthcare Company, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
ARDT
Ardent Health Partners, LLC
$8.81
Mkt Cap: $1.3B
ASTH
Astrana Health, Inc.
$23.87
Mkt Cap: $1.2B
AVAH
Aveanna Healthcare Holdings Inc.
$9.09
Mkt Cap: $1.9B
BKD
Brookdale Senior Living Inc.
$10.79
Mkt Cap: $2.6B
LFST
LifeStance Health Group, Inc.
$7.05
Mkt Cap: $2.7B
MD
Pediatrix Medical Group, Inc.
$21.91
Mkt Cap: $1.9B
NHC
National HealthCare Corporation
$141.64
Mkt Cap: $2.2B
QDEL
QuidelOrtho Corporation
$28.95
Mkt Cap: $2.0B
SEM
Select Medical Holdings Corporation
$15.01
Mkt Cap: $1.9B
Explore stocks similar to ACHC for comparison